Ottawa Heart Failure Risk Scale (OHFRS) Calculator
Clinical Criteria Assessment
Complete the eligibility screen and all 10 OHFRS criteria using findings obtained after initial ED treatment.
Clinical exclusion / ineligibility screen
Screen for the following conditions before interpreting OHFRS. A positive response means this scale should not be used to guide disposition in this patient.
The score supports, but does not replace, clinical judgement. Do not use this tool before initial ED treatment or in patients meeting an exclusion criterion.
About the Ottawa Heart Failure Risk Scale
The Ottawa Heart Failure Risk Scale (OHFRS) is a clinical prediction instrument developed to identify emergency department patients with acute heart failure who are at increased risk of serious adverse events. It is intended to support disposition decisions after initial ED treatment.
The original scale contains 10 clinical and laboratory criteria, with weighted points ranging from 0 to 15. The estimated risk values shown below are those reported for the derivation score strata.
Scoring and estimated risk
| Score | Estimated SAE risk | Category |
|---|---|---|
| 0 | 2.8% | Low |
| 1 | 5.1% | Medium |
| 2 | 9.2% | Medium |
| 3 | 15.9% | High |
| 4 | 26.1% | High |
| 5 | 39.8% | Very High |
| 6 | 55.3% | Very High |
| 7 | 69.8% | Very High |
| 8 | 81.2% | Very High |
| 9 | 89.0% | Very High |
| >9 | >89.0% | Very High |
Outcome definition and application
In the prospective validation study, serious adverse events included death within 30 days, or within 14 days: admission to a monitored unit, intubation, noninvasive ventilation, myocardial infarction, or relapse resulting in hospital admission. Definitions and follow-up windows should be considered when interpreting the reported risk estimates.
In the derivation cohort, admission thresholds of ≥1, ≥2, and ≥3 points corresponded to sensitivities of 95.2%, 80.6%, and 64.5%, respectively. These are study findings, not universal admission rules.
Important limitations
- Developed in Canadian emergency departments; calibration may differ in other healthcare systems and populations.
- The walk-test criterion is assessed after initial ED treatment; inability to perform the test because the patient is too ill is scored positive.
- Troponin should be judged against the assay-specific myocardial infarction threshold and clinical context.
- NT-proBNP is included as a weighted criterion; the validation study found improved sensitivity when quantitative NT-proBNP was available.
- Do not apply the score to patients who meet the listed exclusion criteria or are clinically unstable.
References
DOI: 10.1111/acem.12056
PubMed record
DOI: 10.1111/acem.13141
PubMed record
OHFRS score table (PDF). Secondary educational reference; primary studies remain the evidence basis.
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.